Modeling neurological diseases using iPSC-derived neural cellsiPSC modeling of neurological diseases

被引:0
作者
Li Li
Jianfei Chao
Yanhong Shi
机构
[1] Beckman Research Institute of City of Hope,Division of Stem Cell Biology, Department of Developmental and Stem Cell Biology
[2] Beckman Research Institute of City of Hope,Irell and Manella Graduate School of Biological Sciences
来源
Cell and Tissue Research | 2018年 / 371卷
关键词
iPSC; Neurological diseases; Disease modeling;
D O I
暂无
中图分类号
学科分类号
摘要
Developing efficient models for neurological diseases enables us to uncover disease mechanisms and develop therapeutic strategies to treat them. Discovery of reprogramming somatic cells to induced pluripotent stem cells (iPSCs) has revolutionized the way of modeling human diseases, especially neurological diseases. Currently almost all types of neural cells, including but not limited to neural stem cells, neurons, astrocytes, oligodendrocytes and microglia, can be derived from iPSCs following developmental principles. These iPSC-derived neural cells provide valuable tools for studying neurological disease mechanisms, developing potential therapies, and deepening our understanding of the nervous system.
引用
收藏
页码:143 / 151
页数:8
相关论文
共 760 条
  • [1] Aktas O(2007)Neuronal damage in brain inflammation Arch Neurol 64 185-189
  • [2] Ullrich O(2011)Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells Cell Stem Cell 9 17-23
  • [3] Infante-Duarte C(2009)Breaking the code of DNA binding specificity of TAL-type III effectors Science 326 1509-1512
  • [4] Nitsch R(2010)Oligodendrocytes: biology and pathology Acta Neuropathol 119 37-53
  • [5] Zipp F(2016)A human neurodevelopmental model for Williams syndrome Nature 536 338-343
  • [6] Bar-Nur O(2014)Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons Cell Stem Cell 14 796-809
  • [7] Russ HA(2013)Multiplex genome engineering using CRISPR/Cas systems Science 339 819-823
  • [8] Efrat S(2012)Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease Sci Transl Med 4 141ra190-259
  • [9] Benvenisty N(2014)Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells Stem Cell Rep 3 250-E2252
  • [10] Boch J(2015)Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells Nat Commun 6 6626-601